Prosecution Insights
Prosecution Insights
16 pending office actions • 10 art units • 14 examiners • 0 of 16 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 10 (62%) |
| §112 only | 3 (19%) |
| No statute on record | 3 (19%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERS, ELIZABETH ANNE | 3 | 23.1% | +100.0% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
| OLSEN, KAELEIGH ELIZABETH | 1 | 42.1% | +68.8% |
| TIEN, LUCY MINYU | 1 | 61.3% | +35.6% |
| SONG, JIANFENG | 1 | 56.1% | +33.5% |
| OTTON, ALICIA L | 1 | 65.0% | +9.0% |
| ZHANG SPIERING, DONGXIU | 1 | 35.3% | +85.7% |
| PHAN, DOAN THI-THUC | 1 | 42.7% | +49.8% |
| SCHLIENTZ, NATHAN W | 1 | 41.1% | -20.2% |
| DOUBRAVA, JOHN A | 1 | 76.3% | +27.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | MEYERS, ELIZABETH ANNE | 45d overdue |
| 18272391 | ORAL THIN FILM | MEYERS, ELIZABETH ANNE | 25d overdue |
| 18272205 | ORAL THIN FILMS | MEYERS, ELIZABETH ANNE | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18386904 | MICRONEEDLE SYSTEM FOR APPLYING GLUCAGON-LIKE PEPTIDE ANALOGUES | REYNOLDS, FRED H | 112d overdue |
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | MEYERS, ELIZABETH ANNE | 45d overdue |
| 17913747 | DMEU ENHANCER | SONG, JIANFENG | 45d overdue |
| 18272391 | ORAL THIN FILM | MEYERS, ELIZABETH ANNE | 25d overdue |
| 18272205 | ORAL THIN FILMS | MEYERS, ELIZABETH ANNE | 4d overdue |
| 17786223 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | ZHANG SPIERING, DONGXIU | 19d |
| 17423653 | Support for Microneedle Array | DOUBRAVA, JOHN A | 21d |
| 17786217 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | PHAN, DOAN THI-THUC | 27d |
| Art Unit | Apps |
|---|---|
| 1617 | 3 |
| 1613 | 3 |
| 1616 | 2 |
| 1614 | 2 |
| 1658 | 1 |
| 1619 | 1 |
| 1612 | 1 |
| 1699 | 1 |
| 3783 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18686139 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID | MEYERS, ELIZABETH ANNE | 1617 | Other | Non-Final OA | 45d overdue | Pending | Feb 23, 2024 |
| 18386904 | MICRONEEDLE SYSTEM FOR APPLYING GLUCAGON-LIKE PEPTIDE ANALOGUES | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | 112d overdue | Pending | Nov 03, 2023 |
| 18272441 | MULTI-LAYER ORAL THIN FILM | OLSEN, KAELEIGH ELIZABETH | 1619 | §103 | Final Rejection | 47d | Pending | Jul 14, 2023 |
| 18272405 | OTF COMPOUND CONNECTED BY SEWING | TIEN, LUCY MINYU | 1612 | §103 | Final Rejection | 70d | Pending | Jul 14, 2023 |
| 18272391 | ORAL THIN FILM | MEYERS, ELIZABETH ANNE | 1617 | Other | Final Rejection | 25d overdue | Pending | Jul 14, 2023 |
| 18272205 | ORAL THIN FILMS | MEYERS, ELIZABETH ANNE | 1617 | §103 | Final Rejection | 4d overdue | Pending | Jul 13, 2023 |
| 17913747 | DMEU ENHANCER | SONG, JIANFENG | 1613 | §103 | Final Rejection | 45d overdue | Pending | Sep 22, 2022 |
| 17908434 | IONTOPHORETIC COMPOSITION FOR ADMINISTERING S-KETAMINE | OTTON, ALICIA L | 1699 | §112 | Final Rejection | 26d | Pending | Aug 31, 2022 |
| 17786223 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | ZHANG SPIERING, DONGXIU | 1616 | Other | Final Rejection | 19d | Pending | Jun 16, 2022 |
| 17786217 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | PHAN, DOAN THI-THUC | 1613 | §112 | Non-Final OA | 27d | Pending | Jun 16, 2022 |
| 17597385 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE | SCHLIENTZ, NATHAN W | 1616 | §103 | Non-Final OA | 17d overdue | Pending | Jan 04, 2022 |
| 17423653 | Support for Microneedle Array | DOUBRAVA, JOHN A | 3783 | §103 | Non-Final OA | 21d | Pending | Jul 16, 2021 |
| 17421265 | ORAL THIN FILM | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | 37d overdue | Pending | Jul 07, 2021 |
| 17278844 | TRANSDERMAL THERAPEUTICS SYSTEM WITH BARRIER LAYER | KETCHAM, KAREN A | 1614 | §103 | Non-Final OA | 8d | Pending | Mar 23, 2021 |
| 16765775 | WATER-SOLUBLE POLYMER ADHESIVE LAYERS | HELM, CARALYNNE E | 1615 | §103 | Final Rejection | 34d | Pending | May 20, 2020 |
| 16625401 | SELF-REMINDING PATCH | YU, HONG | 1614 | §103 | Final Rejection | 30d overdue | Pending | Dec 20, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial